
[Federal Register: July 9, 2010 (Volume 75, Number 131)]
[Notices]               
[Page 39541-39543]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09jy10-47]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0306]

 
Agency Information Collection Activities; Proposed Collection; 
Comment Request; ``The Dairy Practitioner's Role in Residue Avoidance 
Survey''

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
opportunity for public comment on the proposed collection of certain 
information by the agency. Under the Paperwork Reduction Act of 1995 
(the PRA), Federal agencies are required to publish notice in the 
Federal Register concerning each proposed collection of information and 
to allow 60 days for public comment in response to the notice. This 
notice solicits comments on FDA's ``The Dairy Practitioner's Role in 
Residue Avoidance Survey.''

DATES:  Submit either electronic or written comments on the collection 
of information by September 7, 2010.

ADDRESSES:  Submit electronic comments on the collection of information 
to http://www.regulations.gov. Submit written

[[Page 39542]]

comments on the collection of information to the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
rm. 1061, Rockville, MD 20852. All comments should be identified with 
the docket number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of 
information Management, Food and Drug Administration, 350 Piccard Dr., 
P150-400B, 301-796-3793.

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal 
agencies must obtain approval from the Office of Management and Budget 
(OMB) for each collection of information they conduct or sponsor. 
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) 
requires Federal agencies to provide a 60-day notice in the Federal 
Register concerning each proposed collection of information before 
submitting the collection to OMB for approval. To comply with this 
requirement, FDA is publishing notice of the proposed collection of 
information set forth in this document.
    With respect to the following collection of information, FDA 
invites comments on these topics: (1) Whether the proposed collection 
of information is necessary for the proper performance of FDA's 
functions, including whether the information will have practical 
utility; (2) the accuracy of FDA's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques, when 
appropriate, and other forms of information technology.

``The Dairy Practitioner's Role in Residue Avoidance Survey'' (OMB 
Control Number--0910-NEW)

    The Food and Drug Administration (FDA), through its Center for 
Veterinary Medicine (CVM), regulates the manufacture and distribution 
of food additives and drugs that will be given to animals. FDA is 
responsible for investigating veterinary drug residue violations in 
meats and providing regulatory action when necessary. In connection 
with this mission, the CVM Office of Surveillance and Compliance (OSC) 
develops programs to promote veterinary drug residue awareness and 
avoidance in order to reduce the risk of drug residues in safeguarding 
the public health. Information will be collected to determine the 
current state of veterinary drug residue avoidance in the dairy 
industry.
    The United States Department of Agriculture (USDA), Food Safety and 
Inspection Service (FSIS) and FDA are responsible for collecting data 
on tissue residues of animal drugs. Information from this survey will 
be analyzed and used to: (1) Identify the respondent's level of 
awareness of the veterinary drug residues in dairy beef; (2) assess the 
current level of participation in the existing residue avoidance 
programs i.e., the Food Animal Residue Avoidance Database and Dairy 
Beef Quality Assurance Program; (3) identify risk factors currently 
associated with drug residues in dairy tissues; and (4) identify the 
best way to disseminate drug residue avoidance information to dairy 
producers. Information from this study will be used to shape the 
Agency's efforts to develop educational materials and to identify ways 
in which the Agency can optimize resources in the area of drug residue 
avoidance. Further, the findings will be presented in a descriptive 
report and informational sheets will be disseminated to animal health 
officials, dairy producers, and veterinarians. Participation in this 
survey is voluntary. It is up to the individual dairy practitioner to 
determine if participation is desirable.
    ``The Dairy Practitioner's Role in Residue Avoidance Survey'' will 
be comprised of a one time study that will employ a web-based self-
administered survey instrument, followed by mailing of the same survey 
in a paper self-administered mode to increase coverage and response 
rate. The instrument will collect information on the respondent's 
knowledge of drug residues in dairy beef and experience with drug 
residues at their clients' dairy farms. The study will be disseminated 
via the American Association of Bovine Practitioners (AABP) e-mail 
list-serve. Mail and electronic correspondence promotional material 
will be disseminated throughout the process to increase response rates.
    FDA estimates the burden of this collection of information as 
follows:

                                 Table 1.--Estimated Annual Reporting Burden\1\
----------------------------------------------------------------------------------------------------------------
                    No. of         Annual Frequency      Total Annual          Hours per
    Study         respondents        per response          Responses           Response           Total Hours
----------------------------------------------------------------------------------------------------------------
Survey                     2,890                   1               2,890                 .33               953.7
----------------------------------------------------------------------------------------------------------------
Total                                                                                         ..................
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.


[[Page 39543]]

    There will be 2,890 respondents for a one-time survey total of 
2,890 annual responses. The hours per response is estimated to be .33 
hours. Thus the total annual burden is estimated to be 953.7 hours. A 
60 percent response rate is expected.

    Dated: July 1, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-16806 Filed 7-8-10; 8:45 am]
BILLING CODE 4160-01-S

